Cooksley, Tim http://orcid.org/0000-0001-6114-1956
Font, Carme
Scotte, Florian
Escalante, Carmen
Johnson, Leslie
Anderson, Ronald
Rapoport, Bernardo
Article History
Received: 3 September 2020
Accepted: 18 November 2020
First Online: 23 November 2020
Compliance with ethical standards
:
: Dr. Rapoport reports grants, personal fees, non-financial support, and advisory boards and is a speaker engagement from Sandoz and speaker engagement from Amgen South Africa, during the conduct of the study. Dr. Scotte reports grants, personal fees, and other from AMGEN; personal fees and other from Mylan; grants, personal fees, and other from Roche; personal fees and other from Mundipharma; personal fees and other from Leo Pharma; personal fees and other from Tesaro; personal fees and other from Helsinn; personal fees and other from Tilray; personal fees and other from Vifor Pharma; personal fees and other from Pfizer; personal fees and other from BMS; and personal fees and other from Pierre Fabre Oncology, outside the submitted work. The other authors declare no conflicts of interest.No ethics approval is required for this position paper.There is no patient consent for participation or publication relevant to this position paper.
Free to read: This content has been made available to all.